Calyxia key facts
- Manufacturer of customizable and biodegradable microcapsules intended to protect active ingredients during industrial processes.
- It has raised $55.1M; the latest was Later Stage VC ($35.0M) in Sep 2024.
- Notable investors include Bpifrance, European Commission, Astanor, Lombard Odier, Lombard Odier Investment Managers — 10 tracked in total.
- Status: Privately Held (backing).
- ·Watch Calyxia: the Monday email on marks, rounds and moves
Calyxia funding rounds
No funding rounds for Calyxia are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Calyxia investors
10 investors are on record for Calyxia, including Bpifrance, European Commission, Astanor and Lombard Odier.
About Calyxia
Manufacturer of customizable and biodegradable microcapsules intended to protect active ingredients during industrial processes. The company produces tailor-made microcapsules for application-specific industrial use cases that contain and protect ingredients against all forms of degradation and deliver at the optimum time and site for higher performance, enabling companies in advanced materials, sustainable agriculture, and home care industries to create newly formulated products with fewer ingredients and better performance features.
- Sector
- Business Products and Services (B2B)
- HQ
- Limeil Brevannes, France
- Founded
- 2015
- Employees
- 107
- Website
- calyxia.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Calyxia doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.